The microbial metabolite desaminotyrosine protects from influenza through type I interferon
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Eat more plants for influenza resilience: Antibiotic treatment worsens influenza in mice, possibly because the concomitant loss of the microbiota interrupts the production of bioactive metabolites. Steed et al. found that a microbial product, desaminotyrosine (DAT), produced by an obligate clostridial anaerobe from the digestion of plant flavonoids, is beneficial during influenza. DAT enters the bloodstream and triggers type I interferon signaling, which then augments antiviral responses by phagocytic cells. Without DAT, influenza virus causes inflammation and severe disease. Science , this issue p. 498
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Desaminotyrosine, a product derived from the gut commensal Clostridium orbiscindens, exerts distal effects on the lung to protect against influenza through modulation of type I IFN signaling.220”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [220]
In the citing paper
“Antibiotic-treated mice exhibited markedly decreased fecal and serum DAT levels, which was associated with attenuated type I IFN responses to influenza infection and increased mortality”
From Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. (2018) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Microbiota regulates immune defense against respiratory tract influenza A virus infection
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019378108 · Cited by 1,502
Cited by
Items 101–200 of 583
The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota
Wang, M., Yu, F., Zhang, Y., Chang, W., & Zhou, M. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.68170 · Cited by 85
“The previous study showed that Clostridium orbiscindensproduced metabolite desaminotyrosine could protect mice from influenza virus infection by activating type I IFN-mediated immune responses [35].”
BackgroundDietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration
Little, A. S., Younker, I. T., Schechter, M. S., Bernardino, P. N., Méheust, R., Stemczynski, J., Scorza, K., Mullowney, M. W., Sharan, D., Waligurski, E., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01560-2 · Cited by 80
“Microbiome-derived hydro-p -coumarate (also called 4-hydroxyphenylpropionate or desaminotyrosine) protects against influenza through type I interferon activation 44,45 .”
BackgroundButyrate Reprograms Expression of Specific Interferon-Stimulated Genes
Chemudupati, M., Smith, A. C., Fillinger, R. J., Kenney, A. D., Zhang, L., Zani, A., Liu, S., Anderson, M. Z., Sharma, A., & Yount, J. S. (2020) · Journal of Virology · doi:10.1128/jvi.00326-20 · Cited by 86
Driving immunity: all roads lead to metabolism
Pearce, E. J., & Pearce, E. L. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.139 · Cited by 84
Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications
Ravetti, S., Garro, A. G., Gaitán, A., Murature, M., Galiano, M., Brignone, S. G., & Palma, S. D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030863 · Cited by 77
“Recent studies have demonstrated the important role of these microbial metabolites in the overall bioactivity of NRG [19,20].”
BackgroundGut‐lung axis and asthma: A historical review on mechanism and future perspective
Song, X., Liang, J., Lin, S., Xie, Y., Ke, C., Ao, D., Lü, J., Chen, X., He, Y., Liu, X., et al. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12356 · Cited by 87
“91 In addition, gut microbiota produces metabolites with pro ‐ and anti ‐ inflammatory potential, such as biogenic amines (including histamine) 92 which have profound effects on asthma through gut ‐ lung interactions.”
Martin, P. K., Marchiando, A., Xu, R., Rudensky, E., Yeung, F., Schuster, S. L., Kernbauer, E., & Cadwell, K. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0229-0 · Cited by 76
A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations
Muller, E., Algavi, Y. M., & Borenstein, E. (2021) · Microbiome · doi:10.1186/s40168-021-01149-z · Cited by 85
“Other microbial metabolites protect from influenza [10] and even improve mental quality of life [11].”
BackgroundThe microbiota: a crucial mediator in gut homeostasis and colonization resistance
Chen, Y., Xiao, L., Zhou, M., & Zhang, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1417864 · Cited by 100
“On the other hand, C. orbiscindens and its metabolite desaminotyrosine were reported to modulate type I IFN signaling, efficiently restraining influenza virus (Steed et al., 2017; Winkler et al., 2020).”
BackgroundBioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche
Wang, Y., Kim, R., Hinman, S. S., Zwarycz, B., Magness, S. T., & Allbritton, N. L. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.008 · Cited by 77
Aguilar‐López, B. A., Moreno‐Altamirano, M. M. B., Dockrell, H. M., Duchen, M. R., & Sánchez‐García, F. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00051 · Cited by 78
Joachim, L., Göttert, S., Sax, A., Steiger, K., Neuhaus, K., Heinrich, P., Fan, K., Orberg, E. T., Kleigrewe, K., Ruland, J., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104834 · Cited by 67
“15 Accordingly, we found that DAT potently enhanced T-cell priming in response to a known IFN-I-inducer but failed to do so as mono-therapy.”
BackgroundInfluentialDeehan, E. C., Antwan, S. A., Witwer, R., Guerra, P., John, T., & Monheit, L. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100329 · Cited by 65
“Interestingly, desamino-tyrosine is only formed through the metabolization of fl avonoids by a speci fi c human-associated gut microbe, Clostridium orbis-cindens [136].”
Chowdhury, C. S., Kinsella, R. L., McNehlan, M. E., Naik, S. K., Lane, D. S., Talukdar, P., Smirnov, A., Dubey, N., Rankin, A. N., McKee, S. R., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.11.008 · Cited by 78
Jain, U., Lai, C.-W., Xiong, S., Goodwin, V. M., Lu, Q., Muegge, B. D., Christophi, G. P., VanDussen, K. L., Cummings, B. P., Young, E., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.019 · Cited by 67
“Such libraries are a powerful source of material for screens of host cell responses relevant to intestinal repair (Kaiko et al., 2016; Steed et al., 2017).”
BackgroundMethodSelf-citationMicrobiota and Immunity during Respiratory Infections: Lung and Gut Affair
Marrella, V., Nicchiotti, F., & Cassani, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074051 · Cited by 79
“In this setting, desaminotyrosine amplified type I IFN signaling in phagocytes via IFN-α / β receptor and STAT1 [185].”
BackgroundHeumel, S., Rodovalho, V. D. R., Urien, C., Specque, F., Rodrigues, P. B., Robil, C., Delval, L., Sencio, V., Descat, A., Deruyter, L., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2325067 · Cited by 72
Ferreira, C., Viana, S., & Reis, F. (2020) · Microorganisms · doi:10.3390/microorganisms8101514 · Cited by 68
“In addition, flavonoid–microbiome interactions were found to be helpful in the treatment of viral infections in two distinct studies with virus influenza involving bacterial processing of flavonoids [167,168].”
BackgroundVignesh, R., Swathirajan, C. R., Tun, Z. H., Rameshkumar, M. R., Solomon, S. S., & Balakrishnan, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607734 · Cited by 69
Outgrowing the Immaturity Myth: The Cost of Defending From Neonatal Infectious Disease
Harbeson, D. J., Ben-Othman, R., Amenyogbe, N., & Kollmann, T. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01077 · Cited by 74
“Recently, the clostridia-derived metabolite desaminotyrosine (DAT) was shown to promote type 1 IFN signaling in lung dendritic cells, resulting in a less damaging response to influenza challenge and an increased animal survival, while the viral burden in DAT-treated mice remained unchanged (81).”
Ji, J., Ge, X., Chen, Y., Zhu, B., Wu, Q., Zhang, J., Shan, J., Cheng, H., & Shi, L. (2019) · The FASEB Journal · doi:10.1096/fj.201802659rr · Cited by 69
“In summary, targeting the gut microbiome, especially with SCFA-producing bacteria, might provide a novel and promising treatment for IBDs (20).”
BackgroundKumova, O. K., Fike, A. J., Thayer, J. L., Nguyen, L. T., Mell, J. C., Pascasio, J. M., Stairiker, C. J., León, L. G., Katsikis, P. D., & Carey, A. J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008072 · Cited by 69
Empirical antibiotic therapy for sepsis: save the anaerobic microbiota
Kullberg, R. F. J., Haak, B. W., Chanderraj, R., Prescott, H. C., Dickson, R. P., & Wiersinga, W. J. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00257-1 · Cited by 67
Rodriguez‐Mateos, A., Weber, T., Skene, S. S., Ottaviani, J. I., Crozier, A., Kelm, M., Schroeter, H., & Heiß, C. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy229 · Cited by 65
The microbiome and prostate cancer
Javier-DesLoges, J. F., McKay, R. R., Swafford, A. D.-E., Sepich‐Poore, G. D., Knight, R. D., & Parsons, J. K. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00413-5 · Cited by 66
“Multiple human microbiomes can be said to fill complex, organ-specific environmental niches and underlie interactions between endogenous microbes and the human body, frequently through the immune system [5], as well as mediating interactions with pathogens [6] Although studies of the human microbiome as an extension o…”
BackgroundStutz, M. R., Dylla, N. P., Pearson, S. D., Lecompte-Osorio, P. A., Nayak, R., Khalid, M., Adler, E., Boissiere, J. C., Lin, H., Leiter, W. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34260-2 · Cited by 73
Nagai, M., Moriyama, M., Ishii, C., Mori, H., Watanabe, H., Nakahara, T., Yamada, T., Ishikawa, D., Ishikawa, T., Hirayama, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39569-0 · Cited by 66
“Although it has increasingly become evident that gut microbiota and their metabolites are important for protection against in fl uenza virus infection 9 – 12 , the effects of body temperature on host defense to in fl uenza virus infection are largely unknown.”
InfluentialShen, J., Hu, R., Zhou, T., Wang, Z., Zhang, Y., Li, S., Chen, G., Jiang, M., Qin, A., & Tang, B. Z. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00650 · Cited by 62
Yang, X.-L., Gan, W., Xie, J., Li, H., Chen, S., Liu, W. Y., & Zhu, S. (2021) · mBio · doi:10.1128/mbio.00366-21 · Cited by 68
“treated mice exhibited blunted type I interferon responses, which are required for optimizing functions of nonmucosal immune cells, including NK cells, macrophages, and CD81 T cells (13, 14, 16, 22).”
BackgroundMethodInfluentialResearch Progress of Flavonoids Regulating Endothelial Function
Li, H., & Zhang, Q. (2023) · Pharmaceuticals · doi:10.3390/ph16091201 · Cited by 69
“phase I metabolites containing some polar functional groups (such as hydroxyl) and some endogenous substances coupled or combined to produce a variety of binding products [97].”
BackgroundGut Microbiota Perturbation in IgA Deficiency Is Influenced by IgA-Autoantibody Status
Moll, J. M., Myers, P. N., Zhang, C., Eriksen, C., Wolf, J., Appelberg, K. S., Lindberg, G., Bahl, M. I., Zhao, H., Pan‐Hammarström, Q., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.053 · Cited by 63
Winkle, J. A. V., Peterson, S. T., Kennedy, E. A., Wheadon, M. J., Ingle, H., Desai, C., Rodgers, R., Constant, D. A., Wright, A. P., Li, L., et al. (2022) · eLife · doi:10.7554/elife.74072 · Cited by 62
Self-citationDistinct Effects of Type I and III Interferons on Enteric Viruses
Ingle, H., Peterson, S. T., & Baldridge, M. T. (2018) · Viruses · doi:10.3390/v10010046 · Cited by 62
“A recent report implicates microbial metabolite desaminotyrosine as a critical regulator of type I IFN and protection against influenza, indicating this may be a key microbiota mediator for antiviral protection [162].”
BackgroundHost genetic susceptibility to viral infections: the role of type I interferon induction
Bourdon, M., Manet, C., & Montagutelli, X. (2020) · Genes and Immunity · doi:10.1038/s41435-020-00116-2 · Cited by 64
Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
Baruch, E. N., Wang, J., & Wargo, J. A. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0877 · Cited by 58
“DAT has been demonstrated to protect mice from influenza virus infection by enhancing type I IFN signaling (27).”
BackgroundNext-Generation Probiotics and Their Metabolites in COVID-19
Gautier, T., Gall‐David, S. L., Sweidan, A., Tamanai‐Shacoori, Z., Jolivet‐Gougeon, A., Loréal, O., & Bousarghin, L. (2021) · Microorganisms · doi:10.3390/microorganisms9050941 · Cited by 61
“This was also confirmed by Steed et al. (2017) who demonstrated DAT protection against influenza and that it decreases lung immunopathology [77].”
BackgroundResultAntibiotic Resistance and Microbiota Response
Santacroce, L., Domenico, M. D., Montagnani, M., & Jirillo, E. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221219093450 · Cited by 64
Wang, G., Liu, J., Zhang, Y., Xie, J., Chen, S., Shi, Y., Shi, F., & Zhu, S. (2023) · The ISME Journal · doi:10.1038/s41396-023-01541-7 · Cited by 59
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Ayala, A. V., Hsu, C.-Y., Oles, R. E., Matsuo, K., Loomis, L. R., Buzun, E., Terrazas, M. C., Gerner, R. R., Lu, H.-H., Kim, S., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230063 · Cited by 66
“Efforts to understand how the microbiota primes the IFN system have largely focused on its involvement in antiviral immunity (Steed et al., 2017; Bradley et al., 2019; Schaupp et al., 2020; Stefan et al., 2020; Yang et al., 2021; Erttmann et al., 2022).”
BackgroundMicrobiome control of innate reactivity
Chen, F., & Stappenbeck, T. S. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.12.003 · Cited by 61
Self-citationShu, G., Kong, F., Xu, D., Yin, L., He, C., Lin, J., Fu, H., Wang, K., Tian, Y., & Zhao, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-69010-1 · Cited by 56
Microbiota-derived metabolites: Key modulators of cancer immunotherapies
Perl, M., Fante, M. A., Herfeld, K., Scherer, J. N., Poeck, H., & Orberg, E. T. (2025) · Med · doi:10.1016/j.medj.2025.100773 · Cited by 66
“36 DAT enhances anti-viral immunity in mice by amplifying IFN-I signaling 37 and boosts ICI efficacy in solid tumor models.”
Cheng, D., Song, J., Xie, M., & Song, D. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.044 · Cited by 59
Wang, L., Huang, G., Hou, R., Qi, D., Wu, Q., Nie, Y., Zuo, Z., Ma, R., Zhou, W., Ma, Y., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01142-6 · Cited by 65
“, improvement of metabolic parameters in obesity and interventions for weight loss [2], immune response enhancement [3], and amelioration of metabolic syndrome [4].”
BackgroundThe danger theory of immunity revisited
Kroemer, G., Montégut, L., Kepp, O., & Zitvogel, L. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01102-9 · Cited by 58
“Desaminotyrosine produced by Clostridium orbiscindens protects from influenza infection and enhances the efficacy of anticancer immunotherapy with inhibitors of CTLA-4 or PD1 by enhancing the IFN-I response 163,164 .”
Li, F., Wang, Y., Song, X., Wang, Z., Jia, J., Qing, S., Huang, L., Wang, S., Wang, S., Ren, Z., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096989 · Cited by 57
“Besides, depletion of gut microbiota by ABX treatment primed activated microglia to proinflammatory state, resulting in enhanced susceptibility to HSV1 brain infection and HSE progression, similar to the prior findings of ABX-treated mice challenged with IAV and HBV.15,16,21 Actually, the microglial immune response pl…”
ResultA Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
Song, L., Huang, Y., Liu, G., Li, X., Xiao, Y., Liu, C., Zhang, Y., Li, J., Xu, J., Lu, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.828887 · Cited by 56
“org 12 outcome due to the excessive inflammatory pathological damage caused by delayed type I IFN response (23).”
BackgroundResultMetabolites as agents and targets for cancer immunotherapy
Trefny, M. P., Kroemer, G., Zitvogel, L., & Kobold, S. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01227-z · Cited by 66
“Following pioneering descriptions of a protective role for the microbial metabolite desaminotyrosine against lung viral infections, interest has been sparked in using this ‘innate immunometabolite’ as an anticancer drug 191 (Fig.”
A long-distance relationship: the commensal gut microbiota and systemic viruses
Winkler, E. S., & Thackray, L. B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.05.009 · Cited by 59
Hagihara, M., Yamashita, M., Ariyoshi, T., Eguchi, S., Minemura, A., Miura, D., Higashi, S., Oka, K., Nonogaki, T., Mori, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111755 · Cited by 59
The role of gut microbial metabolites in the T cell lifecycle
Tran, M. T., Huh, J. R., & Devlin, A. S. (2025) · Nature Immunology · doi:10.1038/s41590-025-02227-2 · Cited by 62
“DAT is a flavonoid metabolism byproduct created via flavonoid degradation by several Clostridia species such as Clostridium orbiscindens and Flavonifractor plautii and can regulate the host cell redox state 54–56 .”
Wei, Y., Gao, J., Kou, Y., Liu, M., Meng, L., Zheng, X., Xu, S., Ming, L., Sun, H., Liu, Z., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902900rr · Cited by 56
Yan, H. H., Walker, F. C., Ali, A., Han, H., Tan, L., Veillon, L. J., Lorenzi, P. L., Baldridge, M. T., & King, K. Y. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006816 · Cited by 54
Stevens, J., Steinmeyer, S. H., Bonfield, M., Peterson, L. S., Wang, T. C., Gray, J. K., Lewkowich, I. P., Xu, Y. J., Du, Y., Guo, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl3981 · Cited by 50
Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections
Feng, C., Jin, C., Liu, K., & Yang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114414 · Cited by 53
Modulation of the gut microbiota to improve innate resistance
Schnupf, P., Gaboriau‐Routhiau, V., & Cerf–Bensussan, N. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.08.003 · Cited by 53
Xiong, Q., Huang, H., Wang, N., Chen, R., Chen, N., Han, H., Wang, Q., Siwko, S. K., Liu, M., Qian, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02289 · Cited by 51
“Furthermore, microbial associated metabolites are also involved in protection from influenza through augmentation of type I interferon (IFN-I) signaling (1).”
BackgroundBratburd, J. R., Keller, C., Vivas, E. I., Gemperline, E., Li, L., Rey, F. E., & Currie, C. R. (2018) · mBio · doi:10.1128/mbio.02032-18 · Cited by 58
Metabolite releasing polymers control dendritic cell function by modulating their energy metabolism
Mangal, J. L., Inamdar, S., Yang, Y., Dutta, S., Wankhede, M., Shi, X., Gu, H., Green, M., Rege, K., Curtis, M., et al. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00790k · Cited by 50
Liang, H., Li, M., Chen, J., Zhou, W., Xia, D., Ding, Q., Yang, Y., Zhang, Z., Ran, C., & Zhou, Z. (2024) · Microbiome · doi:10.1186/s40168-024-01958-y · Cited by 54
Scagnolari, C., & Antonelli, G. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.003 · Cited by 50
“Besides the ability of the microbiota to modulate the IFN response through as yet unclear mechanisms, specific components of the enteric microbiota (i.e. microbial metabolite desaminotyrosine) have been shown to exert distal effects on responses to lethal viral infections through modulation of type I IFN [157] .”
Wang, Y., Zaitsev, K., Lu, Q., Li, S., Schaiff, W. T., Kim, K.-W., Droit, L., Wilen, C. B., Desai, C., Balce, D. R., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0633-0 · Cited by 52
Self-citationKiriyama, Y., Tokumaru, H., Sadamoto, H., Kobayashi, S., & Nochi, H. (2024) · Molecules · doi:10.3390/molecules29215102 · Cited by 52
Flavonoids, a Potential New Insight of Leucaena leucocephala Foliage in Ruminant Health
Xu, Y., Tao, Z., Jin, Y., Yuan, Y., Dong, T. T.-X., Tsim, K. W. K., & Zhou, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02739 · Cited by 47
Gut microecology: Why our microbes could be key to our health
Lu, D., Huang, Y., Kong, Y., Tao, T., & Zhu, X. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110784 · Cited by 49
García-Castillo, V., Tomokiyo, M., Tonetti, F. R., Islam, M. A., Takahashi, H., Kitazawa, H., & Villena, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.568636 · Cited by 50
“This effect has been called “metabolic reprograming” (60) and implies that metabolites such as circulating short-chain fatty acids (61), desaminotyrosine (5), docosahexanoic acid (62), or acetate (4) can reach innate immune cells in the respiratory tract and improve their responses to viral infections.”
BackgroundMicrobiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections
Mindt, B. C., & DiGiandomenico, A. (2022) · Antibiotics · doi:10.3390/antibiotics11040474 · Cited by 50
“Furthermore, supplementation with dietary fibers and the metabolites SCFAs or desaminotyrosine (DAT) conferred protection against viral respiratory infections [79,83,117].”
BackgroundMicrobial Metabolism of Naringin and the Impact on Antioxidant Capacity
Zeng, X., Zheng, Y., He, Y., Zhang, J., Peng, W., & Su, W. (2022) · Nutrients · doi:10.3390/nu14183765 · Cited by 48
Chattopadhyay, I., & Shankar, E. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.590874 · Cited by 47
“It appears that the normal gut microbiota elicits the activation and assembly of inflammasome and T-cell responses by inducing the migration of DCs and macrophages in influenza virus infection (Steed et al., 2017).”
BackgroundA potentially functional yogurt co-fermentation with Gnaphalium affine
Gao, H.-X., Yu, Z., He, Q., Tang, S., & Zeng, W. (2018) · LWT · doi:10.1016/j.lwt.2018.01.085 · Cited by 46
Raval, U., Harary, J. M., Zeng, E., & Pasinetti, G. M. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1775585 · Cited by 45
COVID-19 and the Gut Microbiome: More than a Gut Feeling
van der Lelie, D., & Taghavi, S. (2020) · mSystems · doi:10.1128/msystems.00453-20 · Cited by 47
“Lung stroma were identified as the target of microbiotadriven signals (9) that set the type 1 interferon (IFN-I) signature in these cells as a defense against early viral infection.”
BackgroundDual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19
Baghbani, T., Nikzad, H., Azadbakht, J., Izadpanah, F., & Kashani, H. H. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01483-1 · Cited by 48
Coronavirus disease 2019 and the gut–lung axis
Zhou, D. D., Wang, Q., & Liu, H. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.013 · Cited by 50
Orberg, E. T., Meedt, E., Hiergeist, A., Xue, J., Heinrich, P., Ru, J., Ghimire, S., Miltiadous, O., Lindner, S., Tiefgraber, M., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00669-x · Cited by 49
“4) but (3) the distinct pathways involved in SCFA, tryptophan derivative and DAT synthesis, we developed the IMM risk index (IMM-RI) to associate metabolites with clinical outcomes.”
InfluentialZhi, H., Jin, X., Zhu, H., Li, H., Zhang, Y., Lu, Y., & Chen, D. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112876 · Cited by 45
Battaglini, D., Robba, C., Fedele, A., Trancă, S., Sukkar, S. G., Pilato, V. D., Bassetti, M., Giacobbe, D. R., Vena, A., Patroniti, N. A., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.671714 · Cited by 44
“Desaminotyrosine implements type I IFN signaling of lungs’ phagocytes by promoting genes transcription (45).”
BackgroundRaihan, T., Rabbee, M. F., Roy, P., Choudhury, S., Baek, K.-H., & Azad, A. K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.732256 · Cited by 45
“Neutral (dextran, levan, pullulan, cellulose, scleroglucan and curdlan), anionic (alginate, xanthan, gellan), and cationic (chitin and chitosan) properties of these linear and branched MPS may make them suitable against a variety of viruses (Steed et al., 2017).”
BackgroundZhang, Y., Geng, J., Hong, Y., Li, J., Li, S., Sun, R., Xie, Y., Yan, C., Aa, J., & Wang, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00440 · Cited by 46
“Besides, desaminotyrosine (DAT), produced by a specific gut microbe from the digestion of plant flavonoids, protects the host against influenza through modulation of type I IFN (Steed et al., 2017).”
BackgroundDeciphering Human Microbiota–Host Chemical Interactions
Silpe, J. E., & Balskus, E. P. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01030 · Cited by 45
Chen, T., Su, W., Yan, Z., Wu, H., Zeng, X., Peng, W., Gan, L., Zhang, Y., & Yao, H. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.08.039 · Cited by 41
Figueroa, T., Bessière, P., Coggon, A., Bouwman, K. M., van der Woude, R., Delverdier, M. E., Verheije, M. H., de Vries, R. P., & Volmer, R. (2020) · Journal of Virology · doi:10.1128/jvi.00289-20 · Cited by 42
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Yang, M., Yang, Y., He, Q., Zhu, P., Liu, M., Xu, J., & Zhao, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676232 · Cited by 46
“showed that desaminotyrosine (DAT), a metabolite of the intestinal flora, protects against influenza by increasing type I IFN signalling in macrophages (25).”
BackgroundMethodResultInfluentialHe, N.-X., Wang, Q., Huang, H., Chen, J., Wu, G., Zhu, M.-N., Shao, F., Yan, Z., Sang, Z., Cao, L., et al. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/4839124 · Cited by 41
Intestinal barrier dysfunction as a key driver of severe COVID-19
Tsounis, E. P., Triantos, C. K., Konstantakis, C., Marangos, M. N., & Assimakopoulos, S. F. (2023) · World Journal of Virology · doi:10.5501/wjv.v12.i2.68 · Cited by 43
Faecalibacterium duncaniae as a novel next generation probiotic against influenza
Chollet, L., Heumel, S., Deruyter, L., Bouilloux, F., Delval, L., Robert, V., Gevaert, M.-H., Pichavant, M., Sencio, V., Robil, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1347676 · Cited by 42
“This is in line with other evidence of the key role of the gut microbiota in type I IFN-mediated antiviral immunity (15, 25, 76 – 80).”
BackgroundResultLu, Y., Yuan, H., Liang, S., Li, D., Jiang, P., Wang, X., Zhang, K., & Liu, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603658 · Cited by 45
“The gut microbial metabolite DAT ampli fi es this pathway via a uni fi ed STAT1-IFNAR1 positive feedback loop: it enhances STAT1 phosphorylation to upregulate IFNAR1 expression, creating a cascade that potentiates IFN-I signaling (42, 194).”
Genetic variation regulates opioid-induced respiratory depression in mice
Bubier, J. A., He, H., Philip, V. M., Roy, T., Hernandez, C. M., Bernat, R., Donohue, K. D., O’Hara, B. F., & Chesler, E. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-71804-2 · Cited by 42
VanDussen, K. L., Funkhouser-Jones, L. J., Akey, M. E., Schaefer, D. A., Ackman, K., Riggs, M. W., Stappenbeck, T. S., & Sibley, L. D. (2020) · mBio · doi:10.1128/mbio.02582-20 · Cited by 63
“All metabolites were fi rst screened at 0.5 mM, a concentration that was chosen based on previous metabolite screening studies (28, 29).”
MethodInfluentialSelf-citationFrom the Role of Microbiota in Gut‐Lung Axis to SARS‐CoV‐2 Pathogenesis
Badi, S. A., Tarashi, S., Fateh, A., Rohani, P., Masotti, A., & Siadat, S. D. (2021) · Mediators of Inflammation · doi:10.1155/2021/6611222 · Cited by 41
Helminth–virus interactions: determinants of coinfection outcomes
Desai, P., Diamond, M., & Thackray, L. B. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1961202 · Cited by 43
“Moreover, recently there has been a growing interest in understanding the effects of host microbial metabolites in influencing viral pathogenesis, 41,102,103 and helminths, via changes in the microbiome, could regulate host responses to viral infections.”
Gut microbial metabolites in cancer therapy
Song, P., Peng, Z., & Guo, X. (2025) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.06.016 · Cited by 38
Distal Consequences of Mucosal Infections in Intestinal and Lung Inflammation
Melo-González, F., Sepúlveda-Alfaro, J., Schultz, B. M., Suazo, I. D., Boone, D. L., Kalergis, A. M., & Bueno, S. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877533 · Cited by 39
“For example, it has been demonstrated that the microbial metabolite desaminotyrosine is protective against influenza infection by inducing type I IFN signaling and that administration of desaminotyrosine-producing bacteria restores immunity against Influenza in antibiotic-treated mice (61).”
BackgroundChemical Mechanisms of Colonization Resistance by the Gut Microbial Metabolome
Chang, P. V. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00813 · Cited by 46
Recent Trends of Microbiota-Based Microbial Metabolites Metabolism in Liver Disease
Ganesan, R., Jeong, J., Kim, D. J., & Suk, K. T. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.841281 · Cited by 41
“17 C9H10O3 Upregulates type I interferons (91)”
Wang, Q., Fang, Z., Li, L., Wang, H., Zhu, J., Zhang, P., Lee, Y. K., Zhao, J., Zhang, H., Lu, W., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1001313 · Cited by 42
“For instance, desaminotyrosine, produced in the gut by Clostridium orbiscindens, protects hosts from influenza infection (Steed et al., 2017).”
BackgroundImmunological consequences of microbiome-based therapeutics
Alam, M. Z., Maslanka, J. R., & Abt, M. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1046472 · Cited by 43
Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients—A Narrative Review
He, S., Lin, F., Hu, X., & Pan, P. (2023) · Nutrients · doi:10.3390/nu15224734 · Cited by 36
“If it was given after the infection, it may exacerbate the progression of the disease [155].”
BackgroundThe Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza
Smith, A. M., & Huber, V. C. (2017) · Viral Immunology · doi:10.1089/vim.2017.0138 · Cited by 39
“Recent work in the microbiome field shows that the unique group of microbes that comprise the microbiome changes during infection (29,89,195,232) and may influence SBI disease severity (192).”
BackgroundThe influence of microbiota-derived metabolites on viral infections
Alwin, A., & Karst, S. M. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.05.006 · Cited by 37
Metadata
- Authors
- Steed, A. L., Christophi, G. P., Kaiko, G. E., Sun, L., Goodwin, V. M., Jain, U., Esaulova, E., Artyomov, M. N., Morales, D. J., Holtzman, M. J., Boon, A. C. M., Lenschow, D. J., & Stappenbeck, T. S.
- Affiliations
- Washington University in St. Louis (US)
- ITMO University (RU)
- Corresponding author
- Stappenbeck, Thaddeus S.
- ORCID
- Venue
- Science
- Published
- 2017-08-04
- Volume
- 357
- Issue
- 6350
- Pages
- 498-502
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5753406
- OpenAlex
- W2743370588
- Cited by
- 569
- References
- 55
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 68 · 2023: 74 · 2022: 80 · 2021: 94 · 2020: 78 · 2019: 37 · 2018: 29 · 2017: 8
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Crohn’s Colitis (award312855)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Keywords
- influenza, type I interferon, gut microbiota, microbial metabolites, plant flavonoids, Clostridium, antibiotic-induced dysbiosis, antiviral immunity, phagocytes, inflammation, plant-based diet
- MeSH terms
- Gastrointestinal Microbiome, Animals, Cell Line, Clostridium perfringens, Interferon Type I, Lung, Orthomyxoviridae Infections, Phenylpropionates, Signal Transduction, Mice, Knockout, GTP-Binding Proteins, Mice, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.